alpha-V-beta-3 inhibitor (Anchen)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namealpha-V-beta-3 inhibitor (Anchen)
Drug Alias Namealpha-nu-beta-3 inhibtor (Anchen)integrin protein inhibitor (Anchen)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-V/beta-3 modulators
TargetsIntegrin alpha-V/beta-3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Taiwan University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAnchen Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A